上海九院专家团队成功研发国产听觉脑干植入系统 - 2021年07月12日

A device developed by a Shanghai medical research team to help hearing-impaired people who can't use a cochlea implant is set to enter clinical trials under a deal with a local pharmaceutical company.

The auditory brainstem implant (ABI) was developed by a team led by Dr Wu Hao at Shanghai Ninth People's Hospital which announced the deal on Thursday.

As the first ABI to be developed in China, the device stimulates the cochlear nucleus to provide auditory sensation, and is destined for mass production under the deal. Two similar products are produced in Australia and Austria.